The table below shows Mirum Pharmaceuticals, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$521.31M
$336.89M
$186.37M
$77.06M
$19.14M
$0.00
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
-
-
-
-
-
-
SG&A
$257.03M
MIRM annual revenue (10-K history)
Mirum Pharmaceuticals, Inc. reported annual revenue of $521.31M for fiscal year 2025. That is up 54.7% from $336.89M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
